Patient Guide: Bemarituzumab Plus Chemotherapy and Nivolumab Versus Chemotherapy and Nivolumab for FGFR2b Overexpressed Untreated Advanced Gastric and Gastroesophageal Junction Cancer.

We'll Help You Connect with This Trial

Quri.ai is a free clinical trial matching service. We help patients like you connect directly with research sites conducting this study.

  • ✓ Get matched to the right study location for you
  • ✓ Connect directly with study coordinators at 348 participating sites
  • ✓ Understand eligibility with our simplified screening tool
  • ✓ Free service - we're here to help you access clinical research
Trial ID: NCTNCT05111626
Status: ACTIVE_NOT_RECRUITING
Condition: Gastric Cancer, Gastroesophageal Junction Adenocarcinoma
Phase: PHASE3

Find a Study Location Near You

This study is available at 348 research sites. We'll help you connect with the location that's right for you.

Participating sites include:
  • • Phoenix, Arizona
  • • Cerritos, California
  • • Downey, California
  • • And 345 more locations - let us help you find the closest one

Loading interactive enrollment tools...

The full interactive experience will load momentarily

Bemarituzumab Plus Chemotherapy and Nivolumab Versus Chemotherapy and Nivolumab for FGFR2b Overexpressed Untreated Advanced Gastric and Gastroesophageal Junction Cancer. - Join Clinical Trial NCTNCT05111626

How to Join This Clinical Trial - NCTNCT05111626

Learn how to participate in this PHASE3 trial studying an investigational therapy for Gastric Cancer, Gastroesophageal Junction Adenocarcinoma. Current status: ACTIVE_NOT_RECRUITING.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Gastric Cancer, Gastroesophageal Junction Adenocarcinoma. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Gastric Cancer, Gastroesophageal Junction Adenocarcinoma
Treatment Being Tested
Investigational treatment
Study Phase
PHASE3 - Large-scale efficacy study
Enrollment Status
ACTIVE_NOT_RECRUITING
Study Identifier
NCTNCT05111626 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 348 locations. Find a study site near you:

Clinical Research Site

Phoenix, Arizona 85054 - United States

Status: Contact for availability

Clinical Research Site

Cerritos, California 90703 - United States

Status: Contact for availability

Clinical Research Site

Downey, California 90241 - United States

Status: Contact for availability

Clinical Research Site

Duarte, California 91010 - United States

Status: Contact for availability

Clinical Research Site

Los Angeles, California 90095 - United States

Status: Contact for availability

Clinical Research Site

Orange, California 92868 - United States

Status: Contact for availability

Clinical Research Site

Redondo Beach, California 90277 - United States

Status: Contact for availability

Clinical Research Site

Santa Monica, California 90404 - United States

Status: Contact for availability

Clinical Research Site

Santa Monica, California 90404 - United States

Status: Contact for availability

Clinical Research Site

Sylmar, California 91342 - United States

Status: Contact for availability

And 338 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this PHASE3 clinical trial for Gastric Cancer, Gastroesophageal Junction Adenocarcinoma:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai as Your Clinical Trial Matching Service

Quri.ai is a free clinical trial matching service that helps patients connect with research sites. We make it easier to:

  • Find clinical trials that match your condition
  • Get matched to the right study location near you
  • Connect directly with study coordinators
  • Understand if you qualify with simplified eligibility screening
  • Navigate the enrollment process with personalized support
  • Access new treatments through clinical research participation